{"id":"W4394853075","doi":"10.1002/psp4.13141","title":"Population pharmacokinetics and exposure–response analyses of polatuzumab vedotin in patients with previously untreated <scp>DLBCL</scp> from the <scp>POLARIX</scp> study","year":2024,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Internal medicine; Brentuximab vedotin; Rituximab; Adverse effect; Pharmacokinetics; Oncology; Population; Cyclophosphamide; Dosing; Pharmacology; Gastroenterology; Lymphoma; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002174074,0.0004036514,0.0008770524,0.0003109928,0.0001858513,0.0008381144,0.0003079641,0.0005812809,0.0009317389],"category_scores_gemma":[0.002443298,0.000336659,0.0009940753,0.0003975919,0.0003357351,0.0005670114,0.000275455,0.001241036,0.0002248996],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007859314,"about_ca_system_score_gemma":0.0004539354,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007598736,"about_ca_topic_score_gemma":0.0007090613,"domain_scores_codex":[0.9990197,0.0004474797,0.0000477743,0.0002043964,0.0001917199,0.00008891253],"domain_scores_gemma":[0.9983044,0.000779106,0.0003697682,0.0002323047,0.0001125496,0.0002019078],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2418537,0.006247093,0.5573378,0.0003266166,0.005117801,0.001448462,0.0008469181,0.0237194,0.08071326,0.0005500783,0.002843268,0.07899568],"study_design_scores_gemma":[0.01812611,0.09335503,0.8326792,0.00002922658,0.00251161,0.00210719,0.0002774795,0.03153554,0.011991,0.001223521,0.006041781,0.0001223443],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9982442,0.0002676151,0.0004834508,0.00004462056,0.0000045769,0.00006680726,0.0004658171,0.00002386329,0.0003991173],"genre_scores_gemma":[0.9983048,0.00008429335,0.0002350214,0.00008868214,0.00001369063,0.00004998084,0.001007095,0.00001218009,0.0002042326],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002174074,"threshold_uncertainty_score":0.0114978,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02628133640088636,"score_gpt":0.3321197062955578,"score_spread":0.3058383698946714,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}